23.55
-0.25
(-1.05%)
At close: April 17 at 8:08:17 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
45,491
45,491
58,690
33,317
68,268
Investing Cash Flow
-22,926
-22,926
-15,277
-11,921
-19,336
Financing Cash Flow
-198,413
-198,413
-27,577
-21,995
-21,522
End Cash Position
72,016
72,016
249,660
234,082
234,313
Capital Expenditure
-18,025
-18,025
-18,591
-20,418
-20,701
Issuance of Debt
19
19
22
3
22
Repayment of Debt
-1,047
-1,047
-963
-1,171
-1,254
Repurchase of Capital Stock
-122
-122
-6,362
-12
-4
Free Cash Flow
27,466
27,466
40,099
12,899
47,567
12/31/2020 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRKC.SG Merck KGaA
22.80
-0.87%
MRKC.DU Merck KGaA
22.80
-0.87%
EVT.VI Evotec SE
6.24
+7.21%
R5XA.BE AcelRx Pharmaceuticals Inc
0.4175
-2.22%
MRKC.F Merck KGaA
23.20
+0.87%
BIO.RO Biofarm S.A.
0.6700
-0.30%
131030.KQ DHP Korea Co., Ltd.
6,230.00
-0.80%
MRKC.MU Merck KGaA
23.20
0.00%
EVT.DU Evotec SE
6.37
+9.87%
ATB.RO Antibiotice S.A.
2.0900
+0.72%